The 2023 SABCS® was a huge success, with record attendance and number of submitted abstracts. The premier symposium for breast cancer research, care, and advocacy had plenty of new features, as well as the robust science that is the meeting’s hallmark.

Heide L. Ford, PhD; Jennifer K. Richer, PhD; Ann Partridge, MD, MPH; and Mariana Chavez Mac Gregor, MD, MSC, FASCO, outlined updates across the spectrum of breast cancer research and clinical practice.

Experts reviewed the updates from the 2023 SABCS® that may have an immediate impact for patients and physicians.

Vivek Subbiah, MD, and fellow panelists explored how genomics are driving a new era of tumor-agnostic therapies for cancer in which drugs are approved for biomarkers rather than cancer types.